Lexicon Pharmaceuticals (LXRX +15.4%) moves up today on no company-specific news. The company...

|About: Lexicon Pharmaceuticals, Inc. (LXRX)|By:, SA News Editor

Lexicon Pharmaceuticals (LXRX +15.4%) moves up today on no company-specific news. The company earned fast track status earlier this month from the FDA for its LX1033 drug candidate, an orally delivered small molecule medication for irritable bowel syndrome with diarrhea.